InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (12 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
12
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by ERANI ALBERT, Executive. Officer active across 1 company, notably Organogenesis Holdings Inc.. Cumulatively, 14 filings have been logged. Breakdown: 0 buy · 12 sells. Total volume traded: €8.1m. Activity tracked since 4 June 2021. The latest transaction was filed on 12 November 2024 (J). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations14 total
224,668 shares@ US$3.15977.1% of flowClass A Common StockSEC:0001062993-24-019189:0
224,668 shares@ US$3.15977.1% of flowClass A Common StockSEC:0001062993-24-019188:0
197,921 shares@ US$4.36538.4% of flowClass A Common StockSEC:0001062993-24-000798:0
197,921 shares@ US$4.36538.4% of flowClass A Common StockSEC:0001062993-24-000799:0
25,000 shares@ US$2.07090.5% of flowClass A Common StockSEC:0001062993-23-009196:0
25,000 shares@ US$2.07090.5% of flowClass A Common StockSEC:0001062993-23-009195:0
331 shares@ US$5.300.0003% mcap0.0% of flowClass A Common StockSEC:0001062993-22-014814:0
331 shares@ US$5.300.0003% mcap0.0% of flowClass A Common StockSEC:0001062993-22-014816:0
100,000 shares@ US$5.410.077% mcap7.9% of flowClass A Common StockSEC:0001062993-22-014508:0
100,000 shares@ US$5.410.077% mcap7.9% of flowClass A Common StockSEC:0001062993-22-014506:0
150,000 shares@ US$15.310.29% mcap29.5% of flowClass A Common StockSEC:0001661181-21-000058:0
150,000 shares@ US$15.3120.1% of flowClass A Common StockSEC:0001661181-21-000058
60,000 shares@ US$16.220.12% mcap12.6% of flowClass A Common StockSEC:0001661181-21-000054:0
60,000 shares@ US$16.228.5% of flowClass A Common StockSEC:0001661181-21-000054
14 of 14 declarations
About ERANI ALBERT
Albert Erani is associated with Organogenesis Holdings Inc. Although he does not hold a specific mentioned position, his role within the company contributes to overall leadership and strategy. His expertise in the healthcare field is beneficial for the organization.
